查看購物車
  • English
  • Japanese
  • Korean
核酸樣本製備耗材市場－全球及區域分析：工作流程、樣品來源類型、技術、下游應用、最終使用者、國家－分析與預測（2026-2036年）
市場調查報告書
商品編碼
2151255

核酸樣本製備耗材市場－全球及區域分析：工作流程、樣品來源類型、技術、下游應用、最終使用者、國家－分析與預測（2026-2036年）

Nucleic Acid Sample Preparation Consumables Market - A Global and Regional Analysis: Focus on Workflow, Source Type, Technology, Downstream Application, End User, and Country - Analysis and Forecast, 2026-2036
出版日期: | 出版商: BIS Research | 英文 249 Pages | 商品交期: 1-5個工作天內

價格

全球核酸樣本製備耗材市場預計到 2025 年將達到 18.12 億美元，在現實情況下，到 2036 年將達到 32.074 億美元，2026 年至 2036 年的複合年成長率為 5.21%。

關鍵市場統計數據
預測期 2026-2036
2026 年市場規模 19.305億美元
2036年的預測 32.074億美元
複合年成長率 5.21%

受分子診斷、基因檢測、液態生物檢體、癌症和感染疾病檢測以及微生物定序等技術的日益普及的推動，全球核酸樣本製備耗材市場正穩步擴張。核酸樣本製備耗材是指用於從生物樣本中分離、萃取、純化、清洗、濃縮、定量和製備DNA和RNA的一次性試劑、試劑盒和材料。穩定的樣本品質對於聚合酵素鏈鎖反應（PCR）、定量PCR（qPCR）、次世代定序（NGS）、微陣列、克隆和分子診斷等下游工作流程至關重要。樣本量的增加、重複分子檢測的普及、檢體類型的多樣化以及自動化耗材的日益廣泛應用，都支撐著市場需求的持續成長。

市場概覽

全球核酸樣本製備耗材市場涵蓋用於核酸分離、萃取、純化、淨化、濃縮、定量以及下游分子應用製備的一次性試劑、材料和專用試劑盒。產品包括以微珠為基礎和矽膠的萃取試劑盒、核酸純化和淨化試劑、結合緩衝液、洗滌液、洗脫試劑和定量分析試劑。本調查涵蓋用於處理源自血液、血漿、組織、細胞、唾液、拭子、微生物樣本和其他生物標本的DNA和RNA的耗材。與這些上游工作流程無關的樣本製備服務和產品不在本次調查範圍內。

隨著分子生物學、臨床基因組學和臨床檢測的蓬勃發展，該市場也隨之演變。市場需求正從傳統的手工提取過程轉向適用於高通量自動化實驗室環境的標準化即用型耗材。儘管基於二氧化矽的萃取方法仍被廣泛應用，但磁性顆粒技術因其高效分離、高結合效率、可重複的產量以及與自動化平台的兼容性而日益普及。此外，新的檢測方法需要從片段化的無細胞核酸、保存的組織、低起始量的臨床檢體以及含有抑制劑的樣本中提高回收率。

樣品製備流程始於檢體採集和適當的裂解，隨後進行核酸分離、萃取、純化，必要時進行淨化、濃縮或定量。不同的基質類型和下游製程技術對產量、純度、完整性和抑制劑去除提出了不同的要求。以DNA為基礎的流程包括基因組DNA、遊離DNA、微生物DNA、質體DNA和病毒DNA。以RNA為基礎的流程包括基因組RNA、微生物RNA、病毒RNA和遊離RNA。隨著時間序列癌症監測、傳染病檢查、新一代定序（NGS）和自動化檢查室處理的日益普及，對特定應用的樣品製備方法和一致的樣品製備能力的需求也日益成長。

在這個市場中，各公司在提取效率、可重複性、處理時間、工作流程自動化、與多種樣本來源的兼容性、每次製備成本以及相關臨床應用的法規遵從性等方面展開競爭。隨著學術和研究機構、製藥和生物技術公司、受託研究機構(CRO)、應用檢測實驗室和臨床診斷中心開展的分子檢測活動日益增多，擁有豐富的產品系列、穩定的供應鏈以及與自動化兼容的耗材的供應商有望鞏固其市場地位。

對產業的影響

全球核酸樣品製備耗材市場為分子研究、診斷和應用檢測提供了至關重要的上游工程基礎設施。包括賽默飛世爾科技公司 (Thermo Fisher Scientific Inc.)、凱傑公司 (QIAGEN NV)、丹納赫公司 (Danaher Corporation)、羅氏公司 (F. Hoffmann-La Roche AG)、默克集團 (Merck KGaA)、普羅米加公司 (Promega Corporation)、安捷倫科技公司 (AgilMerck KGaA)、普羅米加公司 (Promega Corporation)、安捷倫科技公司 (Agilp Technologies*) Biolabs)、歐米茄生物科技公司 (Omega Bio-tek, Inc.)、伯樂生命科學公司 (Bio-Rad Laboratories, Inc.) 等在內的領先企業以及專業供應商，正在開發用於核酸提取、純化、淨化和定量分析的耗材。這些產品支持對來自日益多樣化的檢體物種的DNA和RNA進行可靠處理，從而幫助實驗室擴展其分子工作流程。

這些耗材廣泛應用於腫瘤學和液態生物檢體檢測、感染疾病檢測、基因定序、微生物定序、生物生物銀行、藥物研究、法醫學分析以及環境和食品相關檢測。高品質的DNA和RNA提取對於精確的PCR和qPCR擴增、NGS文庫構建以及其他分子檢測至關重要。由於新的生物樣本通常需要新的萃取和純化試劑，因此需求持續存在。重複檢測也會增加每位患者或每個項目的耗材消耗量。此外，無細胞RNA和高分子量DNA應用範圍的不斷擴大，也催生了對具有更高分析物回收率的專用試劑盒的需求。

該市場影響學術和研究機構、製藥和生物技術公司、受託研究機構(CRO)、臨床診斷中心以及應用檢測實驗室。採用自動化磁珠檢測方法可以減少人工處理時間，並提高大批量檢體批次的一致性。然而，高成本、檢體複雜性、基因組資料隱私問題以及臨床產品的監管和品質要求仍然是阻礙因素。能夠提供標準化、可重複性、經濟性和處理能力的供應商可以推動產品在成熟市場和新興市場的應用。

目錄

第1章 市場：產業展望

  • 市場概覽
  • 價格分析
  • 市場吸引力：宏觀與微觀因素分析
  • 監理展望
  • 主要趨勢
    • 從一次性診斷測試過渡到縱向和迭代的分子檢測工作流程。
    • 檢體類型的日益多樣化正在推動對特定應用耗材的需求。
    • 從cfDNA到cfRNA的擴展以及總無細胞核酸萃取
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇

第2章 工作流程

  • 工作流程概要
  • 成長與佔有率矩陣
  • 樣品的分離、萃取與純化
  • DNA/RNA純化與富集
  • DNA/RNA定量

第3章：範例來源類型

  • 樣本來源類型概述
  • 增殖性剪切基質
  • DNA
    • 無細胞DNA
    • 基因組DNA
    • 微生物DNA
    • 質體DNA
    • 病毒DNA
  • RNA
    • 基因組RNA
    • 微生物RNA
    • 病毒RNA
    • 無細胞RNA

第4章 技術

  • 技術概要
  • 成長與佔有率矩陣
  • 二氧化矽基技術
  • 磁粉技術
  • 其他技術

第5章 下游應用

  • 下游應用概述
  • 成長與佔有率矩陣
  • PCR
  • qPCR
  • NGS
  • 複製
  • 微陣列
  • 印跡法
  • 其他用途

第6章 最終用戶

  • 最終用戶摘要
  • 成長與佔有率矩陣
  • 學術研究機構和研究機構
  • 製藥和生物技術公司
  • 合約研究機構
  • 應用考試
  • 臨床診斷中心

第7章 區域

  • 區域概況
  • 北美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 國家
      • 美國
      • 加拿大
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 國家
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 荷蘭
      • 波蘭
      • 葡萄牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 國家
      • 澳洲
      • 中國
      • 印度
      • 日本
      • 馬來西亞
      • 韓國
      • 泰國
      • 台灣
      • 新加坡
      • 印尼
      • 菲律賓
      • 亞太其他地區
  • 拉丁美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 國家
      • 阿根廷
      • 巴西
      • 智利
      • 墨西哥
      • 哥倫比亞
      • 其他拉丁美洲國家
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 國家
      • 沙烏地阿拉伯
      • 南非
      • 阿拉伯聯合大公國
      • 其他中東和非洲地區

第8章 市場－競爭標竿分析與公司概況

  • 產品基準測試
    • 產品基準分析（依供應來源）
  • 關鍵策略和趨勢（按公司分類）
    • 夥伴關係、合作與業務拓展
    • 新產品和服務
  • 企業市場占有率分析
    • DNA
    • RNA
  • 公司簡介
    • Agilent Technologies, Inc.
    • AutoGen Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Macherey-Nagel GmbH &Co KG
    • New England Biolabs
    • Omega Bio-tek, Inc.
    • QIAGEN NV
    • Revvity, Inc.（PerkinElmer, Inc.）
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Zymo Research
    • LGC Biosearch Technologies
    • Danaher Corporation

第9章：調查方法

Product Code: BHL3511SB

This report can be delivered within 1 working day.

Introduction to the Nucleic Acid Sample Preparation Consumables Market

The global nucleic acid sample preparation consumables market, valued at $1,812.0 million in 2025, is projected to reach $3,207.4 million by 2036, registering a compound annual growth rate (CAGR) of 5.21% from 2026 to 2036 under the realistic scenario.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$1,930.5 Million
2036 Forecast$3,207.4 Million
CAGR5.21%

The global nucleic acid sample preparation consumables market is expanding steadily, driven by the increasing use of molecular diagnostics, the growing number of genetic tests, liquid biopsy applications, cancer and infectious disease testing, and microbial sequencing. Nucleic acid sample preparation consumables are single-use reagents, kits, and materials used to isolate, extract, purify, clean up, concentrate, quantify, and prepare DNA or RNA from biological samples. Consistent sample quality is essential for downstream polymerase chain reaction (PCR), quantitative PCR (qPCR), next-generation sequencing (NGS), microarrays, cloning, and molecular diagnostic workflows. Growing sample volumes, the shift toward repeat molecular testing, diversified specimen types, and increasing use of automation-compatible consumables are supporting recurring market demand.

Market Introduction

The global nucleic acid sample preparation consumables market covers single-use reagents, materials, and specialized kits used in nucleic acid isolation, extraction, purification, clean-up, concentration, quantification, and preparation for downstream molecular applications. Products include magnetic bead-based and silica-based extraction kits, nucleic acid purification and clean-up reagents, binding buffers, wash solutions, elution reagents, and quantification assays. The scope includes consumables used for DNA and RNA originating from blood, plasma, tissue, cells, saliva, swabs, microbial samples, and other biological sources. Sample preparation services and products unrelated to these upstream workflows have been excluded.

The market has developed alongside the expansion of molecular biology, clinical genomics, and laboratory testing. Demand has shifted from conventional manual extraction procedures to standardized, ready-to-use consumables suited to high-throughput and automated laboratory environments. Silica-based extraction remains widely established, while magnetic particle technology is increasingly adopted for efficient separation, high binding efficiency, reproducible yields, and compatibility with robotic platforms. New assays also require better recovery from fragmented cell-free nucleic acids, preserved tissues, low-input clinical specimens, and samples containing inhibitors.

Sample preparation workflows begin with sample collection and appropriate lysis, followed by nucleic acid isolation, extraction, purification, and, when required, clean-up, concentration, or quantification. Different matrices and downstream technologies impose distinct requirements for yield, purity, integrity, and inhibitor removal. DNA-based workflows include genomic DNA, cell-free DNA, microbial DNA, plasmid DNA, and viral DNA. RNA-based workflows include genomic RNA, microbial RNA, viral RNA, and cell-free RNA. The growing use of longitudinal cancer monitoring, infectious disease testing, NGS, and automated laboratory processing is increasing demand for application-specific formats and consistent sample-preparation performance.

Companies operating in the market compete on extraction efficiency, reproducibility, hands-on time, workflow automation, compatibility with varied sample sources, per-preparation cost, and regulatory compliance for relevant clinical applications. As academic and research laboratories, pharmaceutical and biotechnology companies, contract research organizations, applied testing laboratories, and clinical diagnostic centers increase molecular testing activity, vendors with broad DNA and RNA portfolios, reliable supply, and automation-ready consumables are positioned to strengthen their market presence.

Industrial Impact

The global nucleic acid sample preparation consumables market provides a fundamental upstream input for molecular research, diagnostics, and applied testing. Leading participants, including Thermo Fisher Scientific Inc., QIAGEN N.V., Danaher Corporation, F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Omega Bio-tek, Inc., Bio-Rad Laboratories, Inc., and specialized suppliers, develop nucleic acid extraction, purification, clean-up, and quantification consumables. Their offerings support reliable processing of DNA and RNA from increasingly diverse sample types and enable laboratories to scale molecular workflows.

These consumables serve oncology and liquid biopsy testing, infectious disease detection, genetic testing, microbial sequencing, biobanking, pharmaceutical research, forensic analysis, and environmental or food-related testing. High-quality extracted DNA and RNA are essential for accurate PCR and qPCR amplification, NGS library input, and other molecular assays. Demand is recurring because new biological samples typically require fresh extraction and purification reagents, and repeat testing increases consumption per patient or project. Expanding cell-free RNA and high-molecular-weight DNA applications are also creating requirements for specialized kits with improved analyte recovery.

The market influences academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, clinical diagnostic centers, and applied testing laboratories. Automation-compatible magnetic bead formats can reduce manual processing time and improve consistency across large sample batches. However, high consumable costs, specimen complexity, genomic-data privacy considerations, and regulatory or quality requirements for clinical-use products remain obstacles. Suppliers that improve standardization, reproducibility, affordability, and throughput can strengthen adoption across both mature and emerging markets.

Market Segmentation:

Segmentation 1: By Workflow

  • Sample Isolation/Extraction/Purification
  • DNA/RNA Clean-Up and Concentration
  • DNA/RNA Quantification

Sample Isolation/Extraction/Purification Segment to Dominate the Market (by Workflow)

In 2025, sample isolation/extraction/purification accounted for 83.02% of the global nucleic acid sample preparation consumables market. This segment dominates because the initial recovery of DNA or RNA is a necessary step for most molecular assays and requires multiple reagents and disposable components per sample. Rising testing volumes, adoption of liquid biopsy, and the use of automated extraction platforms are expected to sustain demand for lysis, binding, washing, and elution consumables throughout the forecast period.

Segmentation 2: By Source Type

  • DNA
    • Cell-Free DNA
    • Genomic DNA
    • Microbial DNA
    • Plasmid DNA
    • Viral DNA
  • RNA
    • Genomic RNA
    • Microbial RNA
    • Viral RNA
    • Cell-Free RNA

DNA Segment to Dominate the Market (by Source Type)

In 2025, DNA accounted for 64.09% of the global nucleic acid sample preparation consumables market. The DNA segment leads because of the widespread use of DNA across genetic testing, clinical diagnostics, cancer research, microbial genomics, PCR, NGS, cloning, and other established molecular techniques. Diverse biological samples and the availability of application-specific genomic, cell-free, microbial, plasmid, and viral DNA kits reinforce demand. RNA workflows, including emerging cell-free RNA analysis, are also expanding as laboratories increasingly assess gene expression and other transcriptional information.

Segmentation 3: By Technology

  • Silica-Based Technology
  • Magnetic Particle Technology
  • Other Technologies

Magnetic Particle Technology Segment to Dominate the Market (by Technology)

In 2025, magnetic particle technology held the largest share of the global nucleic acid sample preparation consumables market at 48.39%. Magnetic bead-based extraction enables efficient nucleic acid binding, consistent recovery, reproducible sample processing, and integration with automated high-throughput systems. Lower hands-on time, scalability across specimen types, and suitability for clinical diagnostics and large-volume research workflows support its market position compared with silica-based and alternative technologies.

Segmentation 4: By Downstream Application

  • PCR
  • qPCR
  • NGS
  • Cloning
  • Microarray
  • Blotting Techniques
  • Other Applications

qPCR Segment to Dominate the Market (by Downstream Application)

In 2025, qPCR accounted for the largest share, 32.11%, of the global nucleic acid sample preparation consumables market by downstream application. qPCR is widely used in infectious disease diagnostics, gene expression analysis, and routine molecular testing, supporting repeat demand for reliable DNA and RNA extraction, purification, and clean-up kits. Established laboratory infrastructure, relatively rapid assay turnaround, and frequent testing volumes contribute to the segment's leadership. NGS and other applications also support growing requirements for highly pure, consistent nucleic acid inputs.

Segmentation 5: By End User

  • Academic Research Institutes and Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Applied Testing
  • Clinical Diagnostic Centers

Academic Research Institutes and Laboratories to Dominate the Market (by End User)

In 2025, academic research institutes and laboratories led the global nucleic acid sample preparation consumables market with a 44.71% share. Their leadership reflects sustained molecular biology and genomic research, the need for high-quality DNA and RNA preparation, and funding for PCR, NGS, and other downstream applications. Pharmaceutical and biotechnology companies, clinical diagnostic centers, contract research organizations, and applied testing laboratories also generate recurring demand for specialized extraction and purification kits.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Poland
    • Portugal
    • Russia
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Singapore
    • Malaysia
    • South Korea
    • Thailand
    • Taiwan
    • Indonesia
    • Philippines
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Rest-of-Latin America
  • Middle East and Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest-of-Middle East and Africa

North America to Dominate the Nucleic Acid Sample Preparation Consumables Market (by Region)

In 2025, North America accounted for the largest share of the global nucleic acid sample preparation consumables market at 46.75%. The region's leadership has been supported by the presence of major life sciences suppliers, advanced molecular diagnostic and research infrastructure, and substantial adoption of nucleic acid-based testing in clinical, academic, and pharmaceutical environments. The U.S. leads regional demand owing to its established laboratories, biotechnology sector, precision medicine activity, and continued utilization of genomic and infectious disease testing.

North America is anticipated to retain a leading position through the forecast period. Growth in Asia-Pacific and other emerging markets is supported by investment in molecular testing capacity, expansion of genomic research, increasing adoption of PCR and NGS workflows, and growing availability of automated sample preparation solutions. Regional uptake will continue to depend on laboratory infrastructure, affordability, regulatory requirements, and access to skilled personnel.

Recent Developments in the Nucleic Acid Sample Preparation Consumables Market

  • In August 2026, New England Biolabs, Inc. launched the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, a phenol-free magnetic bead-based solution for recovery of low-abundance circulating RNA from plasma, serum, urine, and cerebrospinal fluid.
  • In July 2026, QIAGEN N.V. established a distribution partnership with Hamburg Trading Corporation and opened a QIAGEN Experience Lab in the Philippines to support product demonstrations and laboratory automation training.
  • In June 2026, Omega Bio-tek, Inc. launched the Mag-Bind High Molecular Weight DNA Kit (M6311), designed to recover long genomic DNA fragments from blood, buffy coat, saliva, and cultured cells for long-read sequencing applications.
  • In October 2025, AutoGen Inc. partnered with Sampled to connect specialized nucleic acid extraction projects with larger-scale extraction and downstream multi-omics services.

Demand - Drivers, Challenges, and Opportunities

Market Drivers

Increasing Use of Liquid Biopsy and Cell-Free Nucleic Acid Testing: Growing adoption of cell-free DNA, circulating tumor DNA, and related assays in oncology, treatment monitoring, and non-invasive testing supports recurring demand for upstream sample preparation consumables. Low analyte concentration and high fragmentation make efficient extraction and purification important for dependable downstream molecular analysis. Expanding genetic-testing menus, infectious disease surveillance, microbial sequencing, and clinical NGS testing further increases demand for kits that can process varied specimen types with consistent recovery, purity, and low contamination risk.

Market Challenges

High Cost of Nucleic Acid Sample Preparation Consumables: Extraction and purification kit pricing can increase per-sample laboratory expenditure, especially for specialized specimen types, low-input nucleic acids, and high-throughput testing programs. Laboratories must balance performance requirements with reagent consumption, throughput, and assay costs. Clinical-use products may also face quality-system, validation, documentation, and regional regulatory requirements, extending supplier commercialization timelines. Genetic data protection concerns can indirectly affect molecular testing adoption, although they are not intrinsic limitations of extraction consumables.

Market Opportunities

Shift toward Standardized, Ready-to-Use, and Automation-Compatible Consumables: Laboratories are seeking consumables that simplify validated sample preparation, minimize manual handling, improve lot-to-lot consistency, and integrate with automated or semi-automated extraction systems. Expansion of biobanks, longitudinal molecular testing, and diverse specimen processing creates opportunities for reliable formats suited to blood, plasma, FFPE tissue, saliva, microbial, and other samples. Suppliers able to offer traceable reagents, scalable formats, and specialized cfRNA or high-molecular-weight DNA solutions can address evolving workflow requirements.

How can this report add value to an organization?

Product/Innovation Strategy: The global nucleic acid sample preparation consumables market has been segmented by workflow, source type, technology, downstream application, end user, and region. By assessing demand for isolation, extraction, purification, clean-up, quantification, DNA and RNA sample types, and silica- or magnetic particle-based approaches, the report supports product development and portfolio decisions. It also highlights requirements for qPCR, PCR, NGS, and other molecular applications, along with opportunities in automation and low-input sample processing.

Growth/Marketing Strategy: Rising use of liquid biopsy, recurring molecular diagnostics, genetic testing, infectious disease surveillance, microbial sequencing, and biobanking is supporting market demand. Regional expansion and increased laboratory automation are shaping opportunities for consumable suppliers. Developments in cell-free RNA extraction, high-molecular-weight DNA preparation, application-specific kits, and standardized processing formats are important areas for growth and differentiation.

Competitive Strategy: The nucleic acid sample preparation consumables market includes large integrated life sciences companies and specialist kit manufacturers. Players compete on nucleic acid recovery, sample compatibility, reproducibility, throughput, automation, cost per preparation, and technical support. Competitive positioning is being strengthened through new kit introductions, expanded extraction portfolios, distribution partnerships, application-specific innovations, and integration with automated laboratory platforms.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for global market estimation; 2025 is the base year, and 2026 to 2036 is the forecast period.
  • The scope of the report draws on inputs from stakeholders across the nucleic acid sample preparation consumables value chain, including extraction and purification kit suppliers, DNA and RNA consumables manufacturers, magnetic bead and silica technology providers, laboratory automation companies, clinical diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, applied testing providers, and academic and research institutes.
  • Publicly traded companies engaged in nucleic acid sample preparation consumables have been assessed using available financial disclosures and product portfolios. Where direct segment-specific data are unavailable, the research uses relevant company assessments, industry publications, and proxy indicators; the source report identifies these limitations in its market estimation approach.
  • The market has been mapped using commercially available single-use consumables and specialized kits for nucleic acid isolation, extraction, purification, clean-up, concentration, quantification, and preparation. Instruments, sample preparation services, and products unrelated to these activities are excluded. Product-level and segment-level revenue allocation is designed to avoid double counting.

Primary Research

The primary research framework encompasses specialists in molecular biology, molecular diagnostics, genomics, and nucleic acid sample preparation across the consumables value chain. Relevant stakeholder categories include extraction and purification kit manufacturers, reagent suppliers, magnetic particle and silica technology providers, molecular diagnostic laboratories, pharmaceutical and biotechnology companies, contract research organizations, applied testing laboratories, and academic research institutes. Industry and technical perspectives inform assessment of market segmentation, workflow requirements, commercial positioning, and qualitative and quantitative market assumptions.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, peer-reviewed articles, white papers, directories, and major databases, among others
  • Annual reports, regulatory filings, and investor presentations of the leading market players
  • Company websites and a detailed study of their product portfolios
  • Publications and information from scientific and regulatory bodies, including WHO, IARC, NIH, NCBI, FDA, and relevant regional regulatory * authorities, together with product documentation and application guidance
  • Paid databases, including D&B Hoovers, Bloomberg, Factiva, and Bloomberg Businessweek

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs
  • Omega Bio-tek, Inc.
  • Macherey-Nagel GmbH & Co. KG
  • Revvity, Inc.
  • Zymo Research
  • LGC Biosearch Technologies
  • AutoGen Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Pricing Analysis
  • 1.3 Market Attractiveness: Macro and Micro Factor Analysis
  • 1.4 Regulatory Outlook
  • 1.5 Key Trends
    • 1.5.1 Transition from Episodic Diagnostic Testing to Longitudinal and Repeat Molecular Testing Workflows
    • 1.5.2 Increasing Fragmentation of Sample Types Driving Demand for Application-Specific Consumables
    • 1.5.3 Expansion from cfDNA to cfRNA and Total Cell-Free Nucleic Acid Extraction
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Increasing Use of Liquid Biopsy and Cell-Free Nucleic Acid Testing
      • 1.6.1.2 Growing Number of Genetic Tests
      • 1.6.1.3 Increasing Prevalence of Infectious Diseases and Cancer Cases
      • 1.6.1.4 Rise in Microbial Sequencing
      • 1.6.1.5 Increasing Adoption of NGS-Based Testing in Clinical Laboratories
    • 1.6.2 Market Restraints
      • 1.6.2.1 Genomic Data Protection
      • 1.6.2.2 High Cost of Nucleic Acid Sample Preparation Consumables
      • 1.6.2.3 Stringent Regulatory and Quality Compliance Requirements
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Development and Increased Utilization of Biobanks in the Healthcare Segment
      • 1.6.3.2 Shift toward Standardized, Ready-to-Use, and Automation-Compatible Sample Preparation Consumables

2 Workflow

  • 2.1 Workflow Summary
  • 2.2 Growth-Share Matrix
  • 2.3 Sample Isolation/Extraction/Purification
  • 2.4 DNA/RNA Clean-Up and Concentration
  • 2.5 DNA/RNA Quantification

3 Source Type

  • 3.1 Source Type Summary
  • 3.2 Growth-Share Matrix
  • 3.3 DNA
    • 3.3.1 Cell-Free DNA
      • 3.3.1.1 By Sample
      • 3.3.1.2 Blood
      • 3.3.1.3 Serum/Plasma
      • 3.3.1.4 Other Sources
    • 3.3.2 Genomic DNA
      • 3.3.2.1 Blood
      • 3.3.2.2 Body Fluids
      • 3.3.2.3 Buccal
      • 3.3.2.4 Cell/Cultured Cell
      • 3.3.2.5 FFPE
      • 3.3.2.6 Forensic
      • 3.3.2.7 Plant
      • 3.3.2.8 Saliva/Swab
      • 3.3.2.9 Serum/Plasma
      • 3.3.2.10 Tissue
      • 3.3.2.11 Stool, Urine, and Other Samples
    • 3.3.3 Microbial DNA
      • 3.3.3.1 Bacterial
      • 3.3.3.2 Fungus
      • 3.3.3.3 Yeast
      • 3.3.3.4 Other Sources
    • 3.3.4 Plasmid DNA
      • 3.3.4.1 GigaPrep
      • 3.3.4.2 MaxiPrep
      • 3.3.4.3 MegaPrep
      • 3.3.4.4 MidiPrep
      • 3.3.4.5 MiniPrep
    • 3.3.5 Viral DNA
  • 3.4 RNA
    • 3.4.1 Genomic RNA
      • 3.4.1.1 Blood
      • 3.4.1.2 Body Fluids
      • 3.4.1.3 Cell/Cultured Cell
      • 3.4.1.4 FFPE
      • 3.4.1.5 Plant
      • 3.4.1.6 Saliva/Swab
      • 3.4.1.7 Serum/Plasma
      • 3.4.1.8 Tissue
      • 3.4.1.9 Urine
      • 3.4.1.10 Others
    • 3.4.2 Microbial RNA
      • 3.4.2.1 Bacteria
      • 3.4.2.2 Yeast
      • 3.4.2.3 Fungus
      • 3.4.2.4 Others
    • 3.4.3 Viral RNA
    • 3.4.4 Cell-Free RNA
      • 3.4.4.1 Serum/Plasma
      • 3.4.4.2 Others

4 Technology

  • 4.1 Technology Summary
  • 4.2 Growth-Share Matrix
  • 4.3 Silica-Based Technology
  • 4.4 Magnetic Particle Technology
  • 4.5 Other Technologies

5 Downstream Application

  • 5.1 Downstream Applications Summary
  • 5.2 Growth-Share Matrix
  • 5.3 PCR
  • 5.4 qPCR
  • 5.5 NGS
  • 5.6 Cloning
  • 5.7 Microarray
  • 5.8 Blotting Techniques
  • 5.9 Other Applications

6 End User

  • 6.1 End User Summary
  • 6.2 Growth-Share Matrix
  • 6.3 Academic Research Institutes and Laboratories
  • 6.4 Pharmaceutical and Biotechnology Companies
  • 6.5 Contract Research Organizations
  • 6.6 Applied Testing
  • 6.7 Clinical Diagnostic Centers

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 By Country
      • 7.2.4.1 U.S.
      • 7.2.4.2 Canada
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 By Country
      • 7.3.4.1 Germany
      • 7.3.4.2 U.K.
      • 7.3.4.3 France
      • 7.3.4.4 Italy
      • 7.3.4.5 Spain
      • 7.3.4.6 Netherlands
      • 7.3.4.7 Poland
      • 7.3.4.8 Portugal
      • 7.3.4.9 Russia
      • 7.3.4.10 Rest-of-Europe
  • 7.4 Asia Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 By Country
      • 7.4.4.1 Australia
      • 7.4.4.2 China
      • 7.4.4.3 India
      • 7.4.4.4 Japan
      • 7.4.4.5 Malaysia
      • 7.4.4.6 South Korea
      • 7.4.4.7 Thailand
      • 7.4.4.8 Taiwan
      • 7.4.4.9 Singapore
      • 7.4.4.10 Indonesia
      • 7.4.4.11 Philippines
      • 7.4.4.12 Rest-of-Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 By Country
      • 7.5.4.1 Argentina
      • 7.5.4.2 Brazil
      • 7.5.4.3 Chile
      • 7.5.4.4 Mexico
      • 7.5.4.5 Colombia
      • 7.5.4.6 Rest-of-Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 By Country
      • 7.6.4.1 Saudi Arabia
      • 7.6.4.2 South Africa
      • 7.6.4.3 U.A.E.
      • 7.6.4.4 Rest-of-Middle East and Africa

8 Markets - Competitive Benchmarking & Company Profiles

  • 8.1 Product Benchmarking
    • 8.1.1 Product Benchmarking (by Source Type)
      • 8.1.1.1 DNA
      • 8.1.1.2 RNA
  • 8.2 Key Strategies and Developments (by Company)
    • 8.2.1 Partnerships, Collaborations, and Business Expansions
    • 8.2.2 New Offerings
  • 8.3 Company Share Analysis
    • 8.3.1 DNA
      • 8.3.1.1 Cell-Free DNA
      • 8.3.1.2 Genomic DNA
      • 8.3.1.3 Microbial DNA
      • 8.3.1.4 Plasmid DNA
      • 8.3.1.5 Viral DNA
    • 8.3.2 RNA
      • 8.3.2.1 Cell-Free RNA
      • 8.3.2.2 Genomic RNA
      • 8.3.2.3 Microbial RNA
      • 8.3.2.4 Viral RNA
  • 8.4 Company Profiles
    • 8.4.1 Agilent Technologies, Inc.
      • 8.4.1.1 Overview
      • 8.4.1.2 Top Products/Product Portfolio
      • 8.4.1.3 Top Competitors
      • 8.4.1.4 Target Customers
      • 8.4.1.5 Key Personnel
      • 8.4.1.6 Analyst View
    • 8.4.2 AutoGen Inc.
      • 8.4.2.1 Overview
      • 8.4.2.2 Top Products/Product Portfolio
      • 8.4.2.3 Top Competitors
      • 8.4.2.4 Target Customers
      • 8.4.2.5 Key Personnel
      • 8.4.2.6 Analyst View
    • 8.4.3 Bio-Rad Laboratories, Inc.
      • 8.4.3.1 Overview
      • 8.4.3.2 Top Products/Product Portfolio
      • 8.4.3.3 Top Competitors
      • 8.4.3.4 Target Customers
      • 8.4.3.5 Key Personnel
      • 8.4.3.6 Analyst View
    • 8.4.4 F. Hoffmann-La Roche AG
      • 8.4.4.1 Overview
      • 8.4.4.2 Top Products/Product Portfolio
      • 8.4.4.3 Top Competitors
      • 8.4.4.4 Target Customers
      • 8.4.4.5 Key Personnel
      • 8.4.4.6 Analyst View
    • 8.4.5 Merck KGaA
      • 8.4.5.1 Overview
      • 8.4.5.2 Top Products/Product Portfolio
      • 8.4.5.3 Top Competitors
      • 8.4.5.4 Target Customers
      • 8.4.5.5 Key Personnel
      • 8.4.5.6 Analyst View
    • 8.4.6 Macherey-Nagel GmbH & Co KG
      • 8.4.6.1 Overview
      • 8.4.6.2 Top Products/Product Portfolio
      • 8.4.6.3 Top Competitors
      • 8.4.6.4 Target Customers
      • 8.4.6.5 Key Personnel
      • 8.4.6.6 Analyst View
    • 8.4.7 New England Biolabs
      • 8.4.7.1 Overview
      • 8.4.7.2 Top Products/Product Portfolio
      • 8.4.7.3 Top Competitors
      • 8.4.7.4 Target Customers
      • 8.4.7.5 Key Personnel
      • 8.4.7.6 Analyst View
    • 8.4.8 Omega Bio-tek, Inc.
      • 8.4.8.1 Overview
      • 8.4.8.2 Top Products/Product Portfolio
      • 8.4.8.3 Top Competitors
      • 8.4.8.4 Target Customers
      • 8.4.8.5 Key Personnel
      • 8.4.8.6 Analyst View
    • 8.4.9 QIAGEN N.V.
      • 8.4.9.1 Overview
      • 8.4.9.2 Top Products/Product Portfolio
      • 8.4.9.3 Top Competitors
      • 8.4.9.4 Target Customers
      • 8.4.9.5 Key Personnel
      • 8.4.9.6 Analyst View
    • 8.4.10 Revvity, Inc. (PerkinElmer, Inc.)
      • 8.4.10.1 Overview
      • 8.4.10.2 Top Products/Product Portfolio
      • 8.4.10.3 Top Competitors
      • 8.4.10.4 Target Customers
      • 8.4.10.5 Key Personnel
      • 8.4.10.6 Analyst View
    • 8.4.11 Thermo Fisher Scientific Inc.
      • 8.4.11.1 Overview
      • 8.4.11.2 Top Products/Product Portfolio
      • 8.4.11.3 Top Competitors
      • 8.4.11.4 Target Customers
      • 8.4.11.5 Key Personnel
      • 8.4.11.6 Analyst View
    • 8.4.12 Promega Corporation
      • 8.4.12.1 Overview
      • 8.4.12.2 Top Products/Product Portfolio
      • 8.4.12.3 Top Competitors
      • 8.4.12.4 Target Customers
      • 8.4.12.5 Key Personnel
      • 8.4.12.6 Analyst View
    • 8.4.13 Zymo Research
      • 8.4.13.1 Overview
      • 8.4.13.2 Top Products/Product Portfolio
      • 8.4.13.3 Top Competitors
      • 8.4.13.4 Target Customers
      • 8.4.13.5 Key Personnel
      • 8.4.13.6 Analyst View
    • 8.4.14 LGC Biosearch Technologies
      • 8.4.14.1 Overview
      • 8.4.14.2 Top Products/Product Portfolio
      • 8.4.14.3 Top Competitors
      • 8.4.14.4 Target Customers
      • 8.4.14.5 Key Personnel
      • 8.4.14.6 Analyst View
    • 8.4.15 Danaher Corporation
      • 8.4.15.1 Overview
      • 8.4.15.2 Top Products/Product Portfolio
      • 8.4.15.3 Top Competitors
      • 8.4.15.4 Target Customers
      • 8.4.15.5 Key Personnel
      • 8.4.15.6 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Nucleic Acid Sample Preparation Consumables Market (by Scenario), $Million, 2025, 2030, and 2036
  • Figure 2: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2025, 2030, and 2036
  • Figure 3: Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 4: Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), $Million, 2025, 2030, and 2036
  • Figure 5: Global Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 6: Global Nucleic Acid Sample Preparation Consumables Market (by Downstream Application), $Million, 2025, 2030, and 2036
  • Figure 7: Global Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 8: Number of Current Genetic Tests Registered in the GTR, by Intended Purpose, November 2022
  • Figure 9: Global Cancer Incidence, 2018-2022
  • Figure 10: Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), $Million, 2025, 2030, and 2036
  • Figure 11: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by Workflow), 2025-2036
  • Figure 12: Global Nucleic Acid Sample Preparation Consumables Market (Sample Isolation/Extraction/Purification), $Million, 2024-2036
  • Figure 13: Global Nucleic Acid Sample Preparation Consumables Market (DNA/RNA Clean-Up and Concentration), $Million, 2024-2036
  • Figure 14: Global Nucleic Acid Sample Preparation Consumables Market (DNA/RNA Quantification), $Million, 2024-2036
  • Figure 15: Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), $Million,2025, 2030, and 2036
  • Figure 16: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by Source Type), 2025-2036
  • Figure 17: Global Nucleic Acid Sample Preparation Consumables Market (DNA), $Million, 2024-2036
  • Figure 18: Global Nucleic Acid Sample Preparation Consumables Market (Cell-Free DNA), $Million, 2024-2036
  • Figure 19: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Blood), $Million, 2024-2036
  • Figure 20: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Serum/Plasma), $Million, 2024-2036
  • Figure 21: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Cell-Free DNA, By Sample Type, (Other Sources), $Million, 2024-2036
  • Figure 22: Global Nucleic Acid Sample Preparation Consumables Market (Genomic DNA), $Million, 2024-2036
  • Figure 23: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Blood), $Million, 2024-2036
  • Figure 24: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Body Fluids), $Million, 2024-2036
  • Figure 25: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Buccal), $Million, 2024-2036
  • Figure 26: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Cell/Cultured Cell), $Million, 2024-2036
  • Figure 27: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (FFPE), $Million, 2024-2036
  • Figure 28: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Forensic), $Million, 2024-2036
  • Figure 29: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Plant), $Million, 2024-2036
  • Figure 30: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Saliva/Swab), $Million, 2024-2036
  • Figure 31: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Serum/Plasma), $Million, 2024-2036
  • Figure 32: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Tissue), $Million, 2024-2036
  • Figure 33: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Genomic DNA (Stool, Urine, and Other Samples), $Million, 2024-2036
  • Figure 34: Global Nucleic Acid Sample Preparation Consumables Market, DNA (Microbial DNA), $Million, 2024-2036
  • Figure 35: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Microbial DNA (Bacterial), $Million, 2024-2036
  • Figure 36: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Microbial DNA (Fungus), $Million, 2024-2036
  • Figure 37: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Microbial DNA (Yeast), $Million, 2024-2036
  • Figure 38: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Microbial DNA (Other Sources), $Million, 2024-2036
  • Figure 39: Global Nucleic Acid Sample Preparation Consumables Market, DNA (Plasmid DNA), $Million, 2024-2036
  • Figure 40: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Plasmid DNA (GigaPrep), $Million, 2024-2036
  • Figure 41: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Plasmid DNA (MaxiPrep), $Million, 2024-2036
  • Figure 42: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Plasmid DNA (MegaPrep), $Million, 2024-2036
  • Figure 43: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Plasmid DNA (MidiPrep), $Million, 2024-2036
  • Figure 44: Global Nucleic Acid Sample Preparation Consumables Market, DNA, Plasmid DNA (MiniPrep), $Million, 2024-2036
  • Figure 45: Global Nucleic Acid Sample Preparation Consumables Market, DNA (Viral DNA), $Million, 2024-2036
  • Figure 46: Global Nucleic Acid Sample Preparation Consumables Market (RNA), $Million, 2024-2036
  • Figure 47: Global Nucleic Acid Sample Preparation Consumables Market, RNA (Genomic RNA), $Million, 2024-2036
  • Figure 48: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Blood), $Million, 2024-2036
  • Figure 49: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Body Fluids), $Million, 2024-2036
  • Figure 50: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Cell/Cultured Cell), $Million, 2024-2036
  • Figure 51: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (FFPE), $Million, 2024-2036
  • Figure 52: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Plant), $Million, 2024-2036
  • Figure 53: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Saliva/Swab), $Million, 2024-2036
  • Figure 54: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Serum/Plasma), $Million, 2024-2036
  • Figure 55: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Tissue), $Million, 2024-2036
  • Figure 56: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Urine), $Million, 2024-2036
  • Figure 57: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Genomic RNA (Others), $Million, 2024-2036
  • Figure 58: Global Nucleic Acid Sample Preparation Consumables Market, RNA (Microbial RNA), $Million, 2024-2036
  • Figure 59: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Microbial RNA (Bacteria), $Million, 2024-2036
  • Figure 60: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Microbial RNA (Yeast), $Million, 2024-2036
  • Figure 61: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Microbial RNA (Fungus), $Million, 2024-2036
  • Figure 62: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Microbial RNA (Others), $Million, 2024-2036
  • Figure 63: Global Nucleic Acid Sample Preparation Consumables Market, RNA (Viral RNA), $Million, 2024-2036
  • Figure 64: Global Nucleic Acid Sample Preparation Consumables Market, RNA (Cell-Free RNA), $Million, 2024-2036
  • Figure 65: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Cell-Free RNA (Serum/Plasma), $Million, 2024-2036
  • Figure 66: Global Nucleic Acid Sample Preparation Consumables Market, RNA, Cell-Free RNA (Others), $Million, 2024-2036
  • Figure 67: Global Nucleic Acid Sample Preparation Consumables Market (by Technology), $Million, 2025, 2030, and 2036
  • Figure 68: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by Technology), 2025-2036
  • Figure 69: Global Nucleic Acid Sample Preparation Consumables Market (Silica-Based Technology), $Million, 2024-2036
  • Figure 70: Global Nucleic Acid Sample Preparation Consumables Market (Magnetic Particle Technology), $Million, 2024-2036
  • Figure 71: Global Nucleic Acid Sample Preparation Consumables Market (Other Technologies), $Million, 2024-2036
  • Figure 72: Global Nucleic Acid Sample Preparation Consumables Market (by Downstream Applications), $Million, 2025, 2030, and 2036
  • Figure 73: Growth-Share Analysis for Nucleic Acid Sample Preparation Consumables Market (by Downstream Applications), 2025-2036
  • Figure 74: Global Nucleic Acid Sample Preparation Consumables Market (PCR), $Million, 2024-2036
  • Figure 75: Global Nucleic Acid Sample Preparation Consumables Market (qPCR), $Million, 2024-2036
  • Figure 76: Global Nucleic Acid Sample Preparation Consumables Market (NGS), $Million, 2024-2036
  • Figure 77: Global Nucleic Acid Sample Preparation Consumables Market (Cloning), $Million, 2024-2036
  • Figure 78: Global Nucleic Acid Sample Preparation Consumables Market (Microarray), $Million, 2024-2036
  • Figure 79: Global Nucleic Acid Sample Preparation Consumables Market (Blotting Techniques), $Million, 2024-2036
  • Figure 80: Global Nucleic Acid Sample Preparation Consumables Market (Other Applications), $Million, 2024-2036
  • Figure 81: Global Nucleic Acid Sample Preparation Consumables Market (by End User), $Million, 2025, 2030 and 2036
  • Figure 82: Growth-Share Analysis for Global Nucleic Acid Sample Preparation Consumables Market (by End User), 2025-2036
  • Figure 83: Global Nucleic Acid Sample Preparation Consumables Market (Academic Research Institutes and Laboratories), $Million, 2024-2036
  • Figure 84: Global Nucleic Acid Sample Preparation Consumables Market (Pharmaceutical and Biotechnology Companies), $Million, 2024-2036
  • Figure 85: Global Nucleic Acid Sample Preparation Consumables Market (Contract Research Organizations), $Million, 2024-2036
  • Figure 86: Global Nucleic Acid Sample Preparation Consumables Market (Applied Testing), $Million, 2024-2036
  • Figure 87: Global Nucleic Acid Sample Preparation Consumables Market (Clinical Diagnostic Centers), $Million, 2024-2036
  • Figure 88: North America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 89: U.S. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 90: Canada Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 91: Europe Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 92: Germany Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 93: U.K. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 94: France Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 95: Italy Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 96: Spain Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 97: Netherlands Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 98: Poland Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 99: Portugal Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 100: Russia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 101: Rest-of-Europe Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 102: Asia Pacific Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 103: Australia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 104: China Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 105: India Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 106: Japan Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 107: Malaysia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 108: South Korea Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 109: Thailand Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 110: Taiwan Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 111: Singapore Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 112: Indonesia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 113: Philippines Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 114: Rest-of-Asia-Pacific Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 115: Latin America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 116: Argentina Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 117: Brazil Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 118: Chile Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 119: Mexico Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 120: Colombia Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 121: Rest-of-Latin America Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 122: Middle East and Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 123: K.S.A. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 124: South Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 125: U.A.E. Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 126: Rest-of-Middle East and Africa Nucleic Acid Sample Preparation Consumables Market, $Million, 2024-2036
  • Figure 127: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (DNA)
  • Figure 128: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Cell-Free DNA)
  • Figure 129: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Genomic DNA)
  • Figure 130: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Microbial DNA)
  • Figure 131: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Plasmid DNA)
  • Figure 132: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Viral DNA)
  • Figure 133: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (RNA)
  • Figure 134: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Cell-Free RNA)
  • Figure 135: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Genomic RNA)
  • Figure 136: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Microbial RNA)
  • Figure 137: Company Share Analysis, Nucleic Acid Sample Preparation Consumables Market (Viral RNA)
  • Figure 138: Data Triangulation
  • Figure 139: Top-Down and Bottom-Up Approach
  • Figure 140: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pricing of Market Available Consumables
  • Table 3: Global Nucleic Acid Sample Preparation Consumables Market, Market Attractiveness
  • Table 4: Global Nucleic Acid Sample Preparation Consumables Market Regulatory Landscape in U.S., EU, Japan, China, and India
  • Table 5: Impact Analysis of Market Dynamics, 2024-2036
  • Table 6: Global Nucleic Acid Sample Preparation Consumables Market (by Region), $Million, 2024-2036
  • Table 7: Nucleic Acid Sample Preparation Consumables Market, Product Benchmarking (by Source Type, DNA)
  • Table 8: Nucleic Acid Sample Preparation Consumables Market, Product Benchmarking (by Source Type, RNA)